Quick Answer
BIOREGENX, INC. reported Total Revenue of $2.34 million for the year ending 2024.
- BIOREGENX, INC. showed a decrease of -31.4% in Total Revenue from 2023 to 2024.
- This data is from BIOREGENX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $7.7 thousand | Q2 2022: $14.3 thousand | Q3 2022: $11.3 thousand | Q1 2023: $5.6 thousand | Q2 2023: $863.3 thousand | Q3 2023: $794.5 thousand | Q1 2024: $549.5 thousand | Q2 2024: $734.0 thousand | Q3 2024: $596.0 thousand | Q1 2025: $515.1 thousand | Q2 2025: $446.0 thousand | Q3 2025: $507.8 thousand.
- Over the full 4 years of available data (2021 to 2024), BIOREGENX, INC.'s Total Revenue has grown by 1,078.4%.
- Historical annual values: Fiscal year 2024: $2.34 million | Fiscal year 2023: $3.41 million | Fiscal year 2022: $42.2 thousand | Fiscal year 2021: $198.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: